Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
RAJAFTFA Therapeutics, Inc.
| Figure | RAJAFTFA Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $1.25M |
| Revenue, yoy | −0.6% |
| Net income | $154.82K |
| Net income, yoy | +31.6% |
| Net margin | -12.4% |
| Free cash flow | $37.23K |
| FCF margin | — |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed